SAMRATPHPharmaceuticals
Samrat Pharmachem Ltd — Balance Sheet
₹194.95
-7.93%
Samrat Pharmachem Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.31 Cr | 0.31 Cr | 0.31 Cr | 0.31 Cr | — |
| Share Issued | 0.31 Cr | 0.31 Cr | 0.31 Cr | 0.31 Cr | — |
| Net Debt | 9.87 Cr | — | 6.80 Cr | — | 6.29 Cr |
| Total Debt | 9.91 Cr | 8.45 Cr | 18.66 Cr | 7.52 Cr | — |
| Tangible Book Value | 71.79 Cr | 64.99 Cr | 63.14 Cr | 46.81 Cr | — |
| Invested Capital | 81.72 Cr | 73.45 Cr | 81.80 Cr | 54.34 Cr | — |
| Working Capital | 53.78 Cr | 46.17 Cr | 45.86 Cr | 33.93 Cr | — |
| Net Tangible Assets | 71.79 Cr | 64.99 Cr | 63.14 Cr | 46.81 Cr | — |
| Common Stock Equity | 71.80 Cr | 65.00 Cr | 63.14 Cr | 46.82 Cr | — |
| Total Capitalization | 71.80 Cr | 65.00 Cr | 63.14 Cr | 46.82 Cr | — |
| Total Equity Gross Minority Interest | 71.80 Cr | 65.00 Cr | 63.14 Cr | 46.82 Cr | — |
| Stockholders Equity | 71.80 Cr | 65.00 Cr | 63.14 Cr | 46.82 Cr | — |
| Other Equity Interest | 68.71 Cr | 61.91 Cr | 60.05 Cr | 43.73 Cr | — |
| Capital Stock | 3.09 Cr | 3.09 Cr | 3.09 Cr | 3.09 Cr | — |
| Common Stock | 3.09 Cr | 3.09 Cr | 3.09 Cr | 3.09 Cr | — |
| Total Liabilities Net Minority Interest | 49.69 Cr | 56.74 Cr | 53.45 Cr | 37.79 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 0.11 Cr | 0.34 Cr | 0.25 Cr | 0.46 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.11 Cr | 0.34 Cr | 0.25 Cr | 0.46 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Liabilities | 49.58 Cr | 56.40 Cr | 53.19 Cr | 37.33 Cr | — |
| Other Current Liabilities | 22000.00 | -6000.00 | 0.05 Cr | 0.89 Cr | — |
| Current Debt And Capital Lease Obligation | 9.91 Cr | 8.45 Cr | 18.66 Cr | 7.52 Cr | — |
| Current Debt | 9.91 Cr | 8.45 Cr | 18.66 Cr | 7.52 Cr | — |
| Current Provisions | 0.02 Cr | — | — | 5.59 Cr | 0.70 Cr |
| Payables | 39.50 Cr | 47.73 Cr | 31.91 Cr | 23.39 Cr | — |
| Total Tax Payable | 0.94 Cr | 0.00 | 2.14 Cr | 0.88 Cr | — |
| Accounts Payable | 38.56 Cr | 47.67 Cr | 31.88 Cr | 23.39 Cr | — |
| Total Assets | 121.49 Cr | 121.74 Cr | 116.59 Cr | 84.61 Cr | — |
| Total Non Current Assets | 18.13 Cr | 19.17 Cr | 17.54 Cr | 13.35 Cr | — |
| Investmentin Financial Assets | 7.38 Cr | 6.98 Cr | 5.93 Cr | 2.56 Cr | — |
| Available For Sale Securities | 7.38 Cr | 6.98 Cr | 5.93 Cr | 2.56 Cr | — |
| Goodwill And Other Intangible Assets | 0.01 Cr | 66000.00 | 75000.00 | 85000.00 | — |
| Other Intangible Assets | 0.01 Cr | 66000.00 | 75000.00 | 85000.00 | — |
| Net PPE | 10.46 Cr | 10.72 Cr | 10.70 Cr | 9.98 Cr | — |
| Current Assets | 103.36 Cr | 102.57 Cr | 99.05 Cr | 71.26 Cr | — |
| Other Current Assets | 8.28 Cr | 49000.00 | 50000.00 | 0.02 Cr | — |
| Inventory | 38.01 Cr | 20.68 Cr | 32.53 Cr | 12.42 Cr | — |
| Accounts Receivable | 56.54 Cr | 69.28 Cr | 51.67 Cr | 43.57 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.54 Cr | 9.68 Cr | 11.88 Cr | 14.71 Cr | — |
| Other Short Term Investments | 0.49 Cr | 0.01 Cr | 0.01 Cr | 0.01 Cr | — |
| Cash And Cash Equivalents | 0.05 Cr | 9.67 Cr | 11.86 Cr | 14.71 Cr | — |
| Retained Earnings | — | 61.91 Cr | 60.05 Cr | 43.73 Cr | 26.55 Cr |
| Other Non Current Liabilities | — | 6000.00 | — | — | -1000.00 |
| Current Deferred Taxes Liabilities | — | 0.00 | 2.14 Cr | 5.53 Cr | — |
| Dividends Payable | — | 0.06 Cr | 0.03 Cr | 0.00 | 0.00 |
| Other Non Current Assets | — | 0.61 Cr | 0.05 Cr | 1000.00 | -3000.00 |
| Non Current Prepaid Assets | — | 1.18 Cr | 0.66 Cr | 0.60 Cr | 0.44 Cr |
| Non Current Deferred Taxes Assets | — | 0.00 | — | 0.00 | 0.00 |
| Accumulated Depreciation | — | -5.81 Cr | -5.47 Cr | -4.83 Cr | -4.52 Cr |
| Gross PPE | — | 16.53 Cr | 16.16 Cr | 14.80 Cr | 13.92 Cr |
| Machinery Furniture Equipment | — | 10.11 Cr | 9.75 Cr | 8.39 Cr | 7.51 Cr |
| Buildings And Improvements | — | 6.33 Cr | 6.33 Cr | 6.33 Cr | 6.32 Cr |
| Land And Improvements | — | 0.09 Cr | 0.09 Cr | 0.09 Cr | 0.09 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.06 Cr | 0.03 Cr | 0.00 | — |
| Prepaid Assets | — | 2.73 Cr | 2.85 Cr | 0.42 Cr | 0.04 Cr |
| Other Inventories | — | 0.07 Cr | 0.10 Cr | 0.08 Cr | 0.10 Cr |
| Finished Goods | — | 13.92 Cr | 18.34 Cr | 8.90 Cr | 8.65 Cr |
| Work In Process | — | 0.43 Cr | 0.86 Cr | 0.17 Cr | 0.08 Cr |
| Raw Materials | — | 6.25 Cr | 13.23 Cr | 3.35 Cr | 2.57 Cr |
| Other Receivables | — | 0.14 Cr | 0.09 Cr | 0.12 Cr | 0.34 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.02 Cr | -0.02 Cr | -0.02 Cr | 0.00 |
| Gross Accounts Receivable | — | 69.30 Cr | 51.70 Cr | 43.60 Cr | 33.01 Cr |
| Cash Financial | — | 9.67 Cr | 11.86 Cr | 14.71 Cr | 0.24 Cr |
| Other Properties | — | — | 10.70 Cr | 9.98 Cr | 9.39 Cr |
| Taxes Receivable | — | — | 0.00 | 0.00 | 0.00 |
| Capital Lease Obligations | — | — | — | 0.00 | 0.00 |
| Current Capital Lease Obligation | — | — | — | 0.00 | 0.00 |
| Pensionand Other Post Retirement Benefit Plans Current | — | — | — | 5.59 Cr | 0.70 Cr |
| Construction In Progress | — | — | — | 0.00 | 0.00 |
| Cash Equivalents | — | — | — | 2.56 Cr | 2.26 Cr |
| Hedging Assets Current | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Samrat Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.